Loading...
•
Dec 31, 2024
Oscar Health Q4 2024 Earnings Report
Oscar Health reported positive full year results and achieved profitability for the first time.
Key Takeaways
Oscar Health announced its Q4 and full year 2024 results, reporting positive Adjusted EBITDA and net income profitability for the first time in company history. The company's revenue reached $9.2 billion for the year, driven by membership growth and strong retention.
Reported both Adjusted EBITDA and net income profitability.
Achieved all-time-high membership.
Demonstrated ability to deliver sustained profitable growth.
Total Revenue for 2024 was $9.2 billion, a 56.5% increase year-over-year.
Forward Guidance
The Company is introducing its outlook for 2025 including a new metric, Earnings from Operations. For 2025, the Company anticipates Total Revenue of $11.2 billion to $11.3 billion, a Medical Loss Ratio of 80.7% to 81.7%, a SG&A Expense Ratio of 17.6% to 18.1%, and Earnings from Operations of $225 million to $275 million.
Positive Outlook
- Total Revenue of $11.2 billion to $11.3 billion
- Medical Loss Ratio of 80.7% to 81.7%
- SG&A Expense Ratio of 17.6% to 18.1%
- Earnings from Operations of $225 million to $275 million
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...